about
Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA...
Read More
2.08
-0.14
(-6.31%)
1.8M
XNAS Volume
XNAS 24 Sep, 2026 10:47 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Cabaletta Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..